PepGen to Participate in Upcoming Investor Conferences

Rhea-AI Summary

PepGen (Nasdaq: PEPG), a clinical-stage biotechnology company focused on developing next-generation oligonucleotide therapies for severe neuromuscular and neurological diseases, has announced its participation in two upcoming investor conferences.

The company will be present at the Leerink Partners Global Healthcare Conference 2025 in Miami, FL, delivering a Fireside Chat on Tuesday, March 11, 2025, at 3:00 p.m. ET. Additionally, PepGen will participate in the Stifel 2025 Virtual CNS Forum with a Fireside Chat scheduled for Wednesday, March 19, 2025, at 8:00 a.m. ET.

Webcasts of both presentations will be accessible through PepGen's website investor section under 'Events & Presentations'. Replay recordings will remain available for 90 days after each presentation.

BOSTON--(BUSINESS WIRE)-- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that management will participate in the following upcoming investor conferences:

• Leerink Partners Global Healthcare Conference 2025 (Miami, FL)
  • Tuesday, March 11, 2025 at 3:00 p.m. ET, Fireside Chat
• Stifel 2025 Virtual CNS Forum
  • Wednesday, March 19, 2025 at 8:00 a.m. ET, Fireside Chat

A webcast of each conference presentation will be available on the "Events & Presentations" page within the Investors section of the PepGen website at https://investors.pepgen.com/. Replays of the webcasts will be available on the PepGen website for 90 days following the presentation dates.

About PepGen

PepGen is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases. PepGen’s Enhanced Delivery Oligonucleotide (EDO) platform is founded on over a decade of research and development and leverages cell-penetrating peptides to improve the uptake and activity of conjugated oligonucleotide therapeutics. Using these EDO peptides, we are generating a pipeline of oligonucleotide therapeutic candidates designed to target the root cause of serious diseases.

For more information, please visit PepGen.com. Follow PepGen on LinkedIn and X.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250304445181/en/

Investor

Dave Borah, CFA

SVP, Investor Relations and Corporate Communications

dborah@pepgen.com



Media

Julia Deutsch

Lyra Strategic Advisory

Jdeutsch@lyraadvisory.com

Source: PepGen Inc.

FAQ

When is PepGen (PEPG) presenting at the Leerink Partners Healthcare Conference 2025?

PepGen will present at the Leerink Partners Global Healthcare Conference 2025 in Miami on Tuesday, March 11, 2025, at 3:00 p.m. ET.

What is the date and time for PepGen's (PEPG) presentation at the Stifel 2025 Virtual CNS Forum?

PepGen will present at the Stifel 2025 Virtual CNS Forum on Wednesday, March 19, 2025, at 8:00 a.m. ET.

How long will PepGen's (PEPG) investor conference webcasts be available for replay?

The webcasts will be available for replay on PepGen's website for 90 days following each presentation date.

Where can investors access PepGen's (PEPG) conference presentation webcasts?

Investors can access the webcasts through the 'Events & Presentations' page in the Investors section of PepGen's website at investors.pepgen.com.